“Serious skin & soft tissue infections in rheumatoid arthritis patients taking anti-tumor necrosis factor alpha drugs: a nested case–control study”
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
“Serious skin & soft tissue infections in rheumatoid arthritis patients taking anti-tumor necrosis factor alpha drugs: a nested case–control study” ; volume:13 ; number:1 ; day:11 ; month:11 ; year:2013 ; pages:1-7 ; date:12.2013
BMC infectious diseases ; 13, Heft 1 (11.11.2013), 1-7, 12.2013
- Creator
-
Wasson, Ngoc J.
- Contributor
-
Varley, Cara D.
Schwab, Pascal
Fu, Rongwei
Winthrop, Kevin L.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2334-13-533
- URN
-
urn:nbn:de:1111-201603035666
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wasson, Ngoc J.
- Varley, Cara D.
- Schwab, Pascal
- Fu, Rongwei
- Winthrop, Kevin L.
- SpringerLink (Online service)
Other Objects (12)
Golimumab: A Novel Anti-Tumor Necrosis Factor
Anti-tumor necrosis factor therapy in inflammatory bowel disease : 15 tables
Variables associated with general practitioners taking on serious mental disorder patients
Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders
Anti-tumor action of tumor necrosis factor against Bomirski Ab melanoma in hamsters
Successful treatment of Cronkhite–Canada syndrome using anti-tumor necrosis factor antibody therapy
Successful treatment with anti-tumor necrosis factor alpha for reactive small-bowel amyloidosis
Serious porn, serious protest
Anti-tumor necrosis factor patent expiration and the risks of biocopies in clinical practice
Factors that influence rheumatologists’ anti-tumor necrosis factor alpha prescribing decisions: a qualitative study
Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report
Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis
Golimumab: A Novel Anti-Tumor Necrosis Factor
Anti-tumor necrosis factor therapy in inflammatory bowel disease : 15 tables
Variables associated with general practitioners taking on serious mental disorder patients
Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders
Anti-tumor action of tumor necrosis factor against Bomirski Ab melanoma in hamsters
Successful treatment of Cronkhite–Canada syndrome using anti-tumor necrosis factor antibody therapy
Successful treatment with anti-tumor necrosis factor alpha for reactive small-bowel amyloidosis
Serious porn, serious protest
Anti-tumor necrosis factor patent expiration and the risks of biocopies in clinical practice
Factors that influence rheumatologists’ anti-tumor necrosis factor alpha prescribing decisions: a qualitative study
Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report
Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis
Golimumab: A Novel Anti-Tumor Necrosis Factor
Anti-tumor necrosis factor therapy in inflammatory bowel disease : 15 tables
Variables associated with general practitioners taking on serious mental disorder patients
Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders
Anti-tumor action of tumor necrosis factor against Bomirski Ab melanoma in hamsters
Successful treatment of Cronkhite–Canada syndrome using anti-tumor necrosis factor antibody therapy
Successful treatment with anti-tumor necrosis factor alpha for reactive small-bowel amyloidosis
Serious porn, serious protest
Anti-tumor necrosis factor patent expiration and the risks of biocopies in clinical practice
Factors that influence rheumatologists’ anti-tumor necrosis factor alpha prescribing decisions: a qualitative study
Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report